COST 发表于 2025-3-30 12:10:16
Adalimumabmay elicit immune responses that potentially limit its long-term use in patients with chronic conditions such as rheumatoid arthritis, adalimumab is fully human, lowering the potential for immunogenicity (.).咯咯笑 发表于 2025-3-30 13:24:33
http://reply.papertrans.cn/19/1876/187535/187535_52.png